SCHEMBL19082412

SCHEMBL19082412

c1ccc2c(c1)ccc1sc3cc4c(cc3c12)sc1cc(-c2c3ccccc3c(-c3cccc5oc6ccccc6c35)c3ccccc23)ccc14

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
ABCG2 Q9UNQ0 2/20 0.31
AHR P35869 3/20 0.30
PAX8 Q06710 2/20 0.30
NPC1 O15118 1/20 0.30
RAB9A P51151 1/20 0.30
MEN1 O00255 1/20 0.30
TP53 P04637 1/20 0.30
CYP3A4 P08684 1/20 0.30
CYP2D6 P10635 1/20 0.30
MAPT P10636 1/20 0.30
CYP2C9 P11712 1/20 0.30
CYP2C19 P33261 1/20 0.30
KMT2A Q03164 1/20 0.30
NQO1 P15559 1/20 0.30
NQO2 P16083 1/20 0.30
CYP1A1 P04798 1/20 0.30
CYP1A2 P05177 1/20 0.30
FYN P06241 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19082413 0.90 TDP1 (0.36) TDP1L3MBTL1ABCG2
SCHEMBL17945554 0.88 ALDH1A1 (0.37) TDP1L3MBTL1AHRRAB9AMEN1
SCHEMBL23426909 0.88 ALDH1A1 (0.34) TDP1L3MBTL1AHRRAB9AMEN1
SCHEMBL19082109 0.88 NQO2 (0.34) RAB9AMAPTNQO1NQO2CYP1A1
SCHEMBL19082414 0.86 CYP1A1 (0.34) TDP1L3MBTL1CYP1A1CYP1A2
SCHEMBL19082415 0.86 TDP1 (0.36) TDP1L3MBTL1ABCG2AHRPAX8
SCHEMBL19082376 0.84 PIM1 (0.32) NQO1NQO2CYP1A1CYP1A2
SCHEMBL19082408 0.84 TDP1 (0.37) TDP1L3MBTL1ABCG2AHRPAX8
SCHEMBL23427899 0.84 PLA2G2A (0.33) ABCG2NPC1RAB9ATP53CYP3A4
SCHEMBL23428390 0.84 PLA2G2A (0.33) ABCG2NPC1RAB9ATP53CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 TDP1 2322/4885L3MBTL1 1245/4885ABCG2 4823/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 TDP1 2322/4885L3MBTL1 1245/4885ABCG2 4823/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.